0000097476-26-000111.txt : 20260427 0000097476-26-000111.hdr.sgml : 20260427 20260427163121 ACCESSION NUMBER: 0000097476-26-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260424 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lizardi Rafael R CENTRAL INDEX KEY: 0001691660 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03761 FILM NUMBER: 26901489 MAIL ADDRESS: STREET 1: 12500 TI BOULEVARD CITY: DALLAS STATE: TX ZIP: 75243 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEXAS INSTRUMENTS INC CENTRAL INDEX KEY: 0000097476 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing EIN: 750289970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 660199 CITY: DALLAS STATE: TX ZIP: 75266 BUSINESS PHONE: 9729953773 MAIL ADDRESS: STREET 1: 12500 TI BLVD STREET 2: PO BOX 660199 CITY: DALLAS STATE: TX ZIP: 75266 4 1 wk-form4_1777321879.xml FORM 4 X0609 4 2026-04-24 0 0000097476 TEXAS INSTRUMENTS INC TXN 0001691660 Lizardi Rafael R false 12500 TI BOULEVARD DALLAS TX 75243 0 1 0 0 Sr. Vice President & CFO 0 Common Stock 2026-04-24 4 M 0 40541 169.23 A 126026 D Common Stock 2026-04-24 4 S 0 22065 273.7425 D 103961 D Common Stock 2026-04-24 4 S 0 16057 274.7035 D 87904 D Common Stock 2026-04-24 4 S 0 2419 275.5328 D 85485 D Common Stock 33994 I SLAT NQ Stock Option (Right to Buy) 169.23 2026-04-24 4 M 0 40541 0 D 2031-01-28 Common Stock 40541 0 D The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $273.22 to $274.21. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $274.22 to $275.195. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $275.285 to $275.79. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. The option became exercisable in four equal annual installments beginning on January 28, 2022. /s/ Shannon Thompson, Attorney in Fact 2026-04-27